CS MEDICA's CEO and Co-Founder, Lone Henriksen, has been diagnosed with breast cancer and will begin chemotherapy this week. Due to her medical treatment, she will temporarily step down from her executive position. Lone will contribute as CSO (Chief Science Officer), offering support from her vast experience during her recovery.
During Lone's absence, leadership responsibilities will transition to Heidi Ahlefeldt-Laurvig and Gitte Lund Henriksen, who will act as co-CEOs: Heidi Ahlefeldt-Laurvig, CCO & CMO of CS MEDICA, who will oversee overall operations and strategies with a focus on driving growth and achieving sales revenue targets. Gitte Lund Henriksen, CFO & Co-Founder of CS MEDICA, will guide strategic initiatives while managing financing, administration and accounting, ensuring financial stability and effective funding solutions.
